Alamar Biosciences reports 68% Q3 revenue growth and raises annual guidance
ALMR Alamar Biosciences Inc
$31.50 -1.07%
View chart & analysis → - 1Alamar Biosciences recorded a 68% year-over-year total revenue growth in Q3.
- 2Alamar Biosciences achieved a Q3 gross margin of 61.5%.
- 3Alamar Biosciences raised its annual revenue guidance from $121 million to $123 million.
So what's the key point?
Alamar Biosciences' Q3 revenue grew by 68%. The company also increased its annual revenue forecast to $123 million.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.